Toyama, Japan

Yuki Nogami

This inventor holds 1 USPTO granted patent. Top assignees: Kuraray Co., Ltd., Nihon Iyakuhin Kogyo Co., Ltd.. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuki Nogami. Retrieved from https://idiyas.com/inventor/yuki-nogami

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuki Nogami: Innovator in Pharmaceutical Compounds

Introduction

Yuki Nogami is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on geranylgeranylacetamide compounds.

Latest Patents

Yuki Nogami holds a patent for geranylgeranylacetamide compounds having a piperazine ring. This compound is represented by a specific formula, wherein R can be a hydrogen atom, C1-C5 alkyl groups, C2-C5 alkenyl groups, or C7-C8 aralkyl groups. R1 is a C1-C3 alkyl group, and n can be 0, 1, or 2. The compound can be synthesized by reacting geranylgeranylacetic acid or its derivatives with a piperazine compound. The resulting pharmaceutical composition exhibits antiulcerogenic activity, making it particularly useful for treating ulcers.

Career Highlights

Throughout his career, Yuki Nogami has worked with prominent companies such as Nihon Iyakuhin Kogyo Co., Ltd. and Kuraray Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Yuki has collaborated with notable coworkers, including Hiromasa Nakamoto and Michitaka Ogawa. Their joint efforts have further advanced the research and development of pharmaceutical compounds.

Conclusion

Yuki Nogami's contributions to the field of pharmaceuticals, particularly through his patented compounds, highlight his role as an innovator. His work continues to impact the treatment of ulcers and showcases the importance of research in developing effective medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…